Summit Wealth Group LLC Has $464,000 Stock Position in Axon Enterprise, Inc $AXON

by · The Cerbat Gem

Summit Wealth Group LLC lowered its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 44.6% during the 2nd quarter, Holdings Channel.com reports. The firm owned 560 shares of the biotechnology company’s stock after selling 450 shares during the quarter. Summit Wealth Group LLC’s holdings in Axon Enterprise were worth $464,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the stock. Westside Investment Management Inc. raised its holdings in shares of Axon Enterprise by 4.8% during the second quarter. Westside Investment Management Inc. now owns 283 shares of the biotechnology company’s stock valued at $225,000 after purchasing an additional 13 shares during the period. CVA Family Office LLC raised its holdings in shares of Axon Enterprise by 26.9% during the second quarter. CVA Family Office LLC now owns 66 shares of the biotechnology company’s stock valued at $55,000 after purchasing an additional 14 shares during the period. LaSalle St. Investment Advisors LLC raised its holdings in shares of Axon Enterprise by 2.1% during the first quarter. LaSalle St. Investment Advisors LLC now owns 777 shares of the biotechnology company’s stock valued at $408,000 after purchasing an additional 16 shares during the period. Hemington Wealth Management raised its holdings in shares of Axon Enterprise by 70.8% during the second quarter. Hemington Wealth Management now owns 41 shares of the biotechnology company’s stock valued at $33,000 after purchasing an additional 17 shares during the period. Finally, Washington Trust Advisors Inc. raised its holdings in shares of Axon Enterprise by 44.7% during the second quarter. Washington Trust Advisors Inc. now owns 55 shares of the biotechnology company’s stock valued at $46,000 after purchasing an additional 17 shares during the period. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Price Performance

Shares of Axon Enterprise stock opened at $639.53 on Thursday. The company’s fifty day simple moving average is $726.40 and its two-hundred day simple moving average is $735.39. The firm has a market cap of $50.21 billion, a PE ratio of 157.91, a price-to-earnings-growth ratio of 29.49 and a beta of 1.45. The company has a quick ratio of 2.71, a current ratio of 2.95 and a debt-to-equity ratio of 0.63. Axon Enterprise, Inc has a 12-month low of $450.72 and a 12-month high of $885.91.

Axon Enterprise (NASDAQ:AXON – Get Free Report) last announced its earnings results on Tuesday, November 4th. The biotechnology company reported $1.17 earnings per share for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.46). The company had revenue of $710.64 million for the quarter, compared to the consensus estimate of $704.83 million. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The company’s revenue for the quarter was up 30.6% on a year-over-year basis. During the same period in the previous year, the firm posted $1.45 EPS. Axon Enterprise has set its Q4 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, equities analysts expect that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Wall Street Analysts Forecast Growth

AXON has been the topic of a number of analyst reports. Cowen restated a “buy” rating on shares of Axon Enterprise in a report on Wednesday. Morgan Stanley set a $885.00 price objective on shares of Axon Enterprise and gave the stock an “overweight” rating in a research report on Friday, July 11th. Raymond James Financial reaffirmed an “outperform” rating and issued a $855.00 price objective (up from $645.00) on shares of Axon Enterprise in a research report on Tuesday, August 5th. Bank of America upped their price objective on shares of Axon Enterprise from $895.00 to $1,000.00 and gave the stock a “buy” rating in a research report on Wednesday, August 6th. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $870.00 price objective on shares of Axon Enterprise in a research report on Wednesday, September 24th. Fifteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Axon Enterprise currently has a consensus rating of “Moderate Buy” and an average price target of $813.07.

View Our Latest Analysis on Axon Enterprise

Insider Activity at Axon Enterprise

In related news, insider Jeffrey C. Kunins sold 7,891 shares of Axon Enterprise stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $750.10, for a total transaction of $5,919,039.10. Following the completion of the transaction, the insider directly owned 144,538 shares of the company’s stock, valued at $108,417,953.80. This trade represents a 5.18% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, President Joshua Isner sold 15,919 shares of Axon Enterprise stock in a transaction dated Friday, August 15th. The shares were sold at an average price of $746.26, for a total transaction of $11,879,712.94. Following the transaction, the president directly owned 238,379 shares of the company’s stock, valued at approximately $177,892,712.54. This trade represents a 6.26% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 59,932 shares of company stock worth $45,115,616 over the last 90 days. 4.40% of the stock is currently owned by insiders.

Axon Enterprise Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Recommended Stories

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).